14.00
前日終値:
$14.22
開ける:
$14.25
24時間の取引高:
450.81K
Relative Volume:
0.85
時価総額:
$705.63M
収益:
$176.18M
当期純損益:
$-36.26M
株価収益率:
-15.01
EPS:
-0.9326
ネットキャッシュフロー:
$-28.09M
1週間 パフォーマンス:
+6.54%
1か月 パフォーマンス:
+33.08%
6か月 パフォーマンス:
+59.45%
1年 パフォーマンス:
+125.08%
Cryoport Inc Stock (CYRX) Company Profile
名前
Cryoport Inc
セクター
電話
(949) 232-1900
住所
112 WESTWOOD PLACE, SUITE 350, BRENTWOOD
Compare CYRX vs FDX, UPS, JBHT, EXPD, CHRW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CYRX
Cryoport Inc
|
14.00 | 716.72M | 176.18M | -36.26M | -28.09M | -0.9326 |
|
FDX
Fedex Corp
|
394.20 | 92.80B | 91.93B | 4.48B | 4.37B | 18.79 |
|
UPS
United Parcel Service Inc
|
101.02 | 83.51B | 88.37B | 5.25B | 4.52B | 6.1769 |
|
JBHT
J B Hunt Transport Services Inc
|
258.77 | 24.45B | 12.13B | 622.10M | 1.03B | 6.4596 |
|
EXPD
Expeditors International Of Washington Inc
|
158.48 | 20.56B | 11.19B | 837.99M | 920.55M | 6.1898 |
|
CHRW
C H Robinson Worldwide Inc
|
174.23 | 21.00B | 16.20B | 599.01M | 807.11M | 4.9401 |
Cryoport Inc Stock (CYRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-06 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-08-06 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-07-22 | 再開されました | Stephens | Overweight |
| 2025-03-24 | アップグレード | UBS | Neutral → Buy |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-08-07 | ダウングレード | Jefferies | Buy → Hold |
| 2024-07-31 | アップグレード | B. Riley Securities | Neutral → Buy |
| 2024-05-03 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2024-04-04 | 再開されました | Jefferies | Buy |
| 2024-03-13 | 繰り返されました | Needham | Buy |
| 2023-08-17 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-08-10 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2023-07-18 | ダウングレード | UBS | Buy → Neutral |
| 2023-07-17 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-07-13 | ダウングレード | SVB Securities | Outperform → Market Perform |
| 2022-01-19 | アップグレード | ROTH Capital | Neutral → Buy |
| 2021-11-05 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2021-10-19 | 再開されました | B. Riley Securities | Buy |
| 2021-07-16 | 開始されました | BTIG Research | Buy |
| 2021-03-15 | 開始されました | UBS | Buy |
| 2021-03-02 | 再開されました | Needham | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-01-08 | 開始されました | Stephens | Overweight |
| 2019-07-01 | 再開されました | Needham | Buy |
| 2018-10-10 | 開始されました | B. Riley FBR | Buy |
| 2018-08-13 | 繰り返されました | Cowen | Outperform |
| 2018-07-02 | 繰り返されました | Needham | Buy |
| 2018-03-08 | 繰り返されました | Needham | Buy |
| 2017-11-30 | 開始されました | ROTH Capital | Buy |
| 2017-09-12 | 繰り返されました | Cowen | Outperform |
| 2017-08-31 | 繰り返されました | Needham | Buy |
| 2017-08-09 | 繰り返されました | Cowen | Outperform |
| 2017-07-26 | 繰り返されました | Needham | Buy |
| 2017-07-12 | 開始されました | Janney | Buy |
| 2017-06-16 | 開始されました | Cowen | Outperform |
| 2017-06-01 | 繰り返されました | Needham | Buy |
| 2017-04-03 | 開始されました | Needham | Buy |
すべてを表示
Cryoport Inc (CYRX) 最新ニュース
Investors Buy High Volume of CryoPort Call Options (NASDAQ:CYRX) - MarketBeat
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Redwire (RDW) and CryoPort (CYRX) - The Globe and Mail
CYRX Maintained by Keybanc -- Price Target Raised to $17.00 - GuruFocus
Cryoport Is Maintained at Overweight by Keybanc - Moomoo
KeyBanc raises CryoPort stock price target to $17 on growth outlook - Investing.com
Cryoport Earnings Call Highlights Growth and Near-Term Caution - TipRanks
Understanding Momentum Shifts in (CYRX) - Stock Traders Daily
Cryoport Inc stock (US2289031005): earnings update keeps focus on biotech logistics growth - AD HOC NEWS
Cryoport Powers Cell Therapy Boom, Eyes Profitability Amid Record Growth - BriefGlance
Cryoport Inc stock (US2289031005): Q1 revenue beats estimates in volatile cell and gene logistics ma - AD HOC NEWS
CryoPort, Inc. $CYRX Shares Acquired by UBS Group AG - MarketBeat
CYRX | CryoPort, Inc. Common Stock FinancialsIncome Statement - Quiver Quantitative
CryoPort, Inc.Common Stock (NQ: CYRX - FinancialContent
Cryoport Inc stock (US2289031005): Short interest drops to 4.86% as of April 30 - AD HOC NEWS
Cryoport posts revenue beat in Q1 as clinical trial support hits all-time high — 'A strong start to 2026' - MSN
Number of shareholders of CryoPort, Inc. – NASDAQ:CYRX - TradingView
Cryoport projects $192M-$196M FY 2026 revenue and expects positive adjusted EBITDA in 2H 2026 - MSN
CryoPort (NASDAQ:CYRX) Upgraded at Wall Street Zen - MarketBeat
Cryoport (CYRX) Q1 2025 Earnings Transcript - AOL.com
Roth MKM Maintains Cryoport(CYRX.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Cryoport stock is a buy, this analyst says - Cantech Letter
Analysts Conflicted on These Industrial Goods Names: CryoPort (CYRX) and Thomson Reuters (TRI) - The Globe and Mail
CryoPort Q1 2026 earnings preview - MSN
Cryoport Is Maintained at Buy by Guggenheim - Moomoo
CryoPort, Inc. (CYRX) reports Q1 loss, tops revenue estimates - MSN
Cryoport (CYRX) Q2 2025 Earnings Transcript - AOL.com
Analysts Offer Insights on Industrial Goods Companies: V2X (VVX) and CryoPort (CYRX) - The Globe and Mail
Analysts’ Top Industrial Goods Picks: Union Pacific (UNP), CryoPort (CYRX) - The Globe and Mail
CryoPort (NASDAQ:CYRX) Hits New 12-Month High on Analyst Upgrade - MarketBeat
Cryoport Inc. Signals Growth Momentum in Earnings Call - TipRanks
Cryoport | 10-Q: Q1 2026 Earnings Report - Moomoo
Cryoport, Inc. 1Q 2026: Revenue $47.8M, EPS ($0.25) — 10-Q Summary - TradingView
Cryoport (CYRX) lifts Q1 2026 revenue to $47.8M while trimming net loss - Stock Titan
Cryoport Posts Revenue Beat In Q1 As Clinical Trial Support Hits All-Time High — 'A Strong Start To 2026' - Sahm
CryoPort (NASDAQ:CYRX) Shares Gap Up on Analyst Upgrade - MarketBeat
MoCo Minute | Biotechnology company CaleoBio advancing stem cell-based research - AOL.com
Cryoport price target raised to $17 from $15 at BTIG - TipRanks
Cryoport Lifts Guidance, HSBC Misses on Fraud Charge - Gotrade
CryoPort (NASDAQ:CYRX) Price Target Raised to $15.00 - MarketBeat
Cryoport | 8-K: Cryoport Reports First Quarter 2026 Financial Results - Moomoo
Needham Maintains Cryoport(CYRX.US) With Buy Rating, Raises Target Price to $15 - Moomoo
Guggenheim Maintains Cryoport(CYRX.US) With Buy Rating, Raises Target Price to $12 - Moomoo
CryoPort (NASDAQ:CYRX) Price Target Raised to $17.00 - MarketBeat
Cryoport Price Target Raised to $12.00/Share From $11.00 by Guggenheim - Moomoo
Cryoport price target raised to $12 from $11 at Guggenheim - TipRanks
Cryoport, Inc. (NASDAQ:CYRX) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG Maintains Cryoport(CYRX.US) With Buy Rating, Raises Target Price to $17 - Moomoo
Needham raises CryoPort stock price target to $15 on revenue beat By Investing.com - Investing.com South Africa
Needham raises CryoPort stock price target to $15 on revenue beat - Investing.com Australia
BTIG raises CryoPort stock price target to $17 on strong results By Investing.com - Investing.com India
BTIG raises CryoPort stock price target to $17 on strong results - Investing.com UK
Cryoport Inc (CYRX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):